Blog

Boston biotech Rhythm’s stock jumps on success of drug for rare form of obesity

gottesdienerrhythm900xx800-533-0-0

Rhythm’s drug was linked to an average weight drop of 12 and 25 percent in two groups of people with separate, rare gene mutations.

Read More